
Dr. Daniel Couriel
Director, Transplantation and Cellular Therapy[linebreak]Huntsman Cancer Institute, University of Utah[linebreak]United States
I am the Director of Transplantation and Cellular Therapy at Huntsman Cancer Institute, University of Utah. I am a tenure-track Professor and hold the HCI Endowed Professorship in Adult Leukemia Research. My area of research has focused on the diagnosis, prevention and innovative therapies for both acute and chronic GVHD. My clinical research career started in 1999 at the University of Texas MD Anderson Cancer Center, continued at the University of Michigan and now in my current position. I was co-Chair for the GVHD subcommittee in the Center for International Blood and Marrow Transplant Research (2014-2018), and the Ancillary and Supportive Care Subcommittee of the NIH Consensus for Clinical Trials in chronic GVHD. I am in the Board of Directors for the Foundation for Accreditation of Cellular Therapy (FACT), where I have served as an inspector and on several different committees for the last several years. I became particularly interested in expanding our limited access to new cellular therapies to the community and also globally, to areas with the higher levels of inequities.
11:40 - 12:00
Saturday 26 October, Track 1
CAR-T treatment updates
Access to Cellular Therapy